Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
Condition: Type 1 Diabetes Intervention: Drug: Semaglutide weekly injection Sponsor: Ministry of Health, Saudi Arabia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials